nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—exocrine gland—allergic rhinitis	0.0598	0.204	CbGeAlD
Auranofin—PRDX5—respiratory system—allergic rhinitis	0.0311	0.106	CbGeAlD
Auranofin—PRDX5—eye—allergic rhinitis	0.0284	0.097	CbGeAlD
Auranofin—PRDX5—epithelium—allergic rhinitis	0.026	0.0887	CbGeAlD
Auranofin—PRDX5—bronchus—allergic rhinitis	0.0256	0.0873	CbGeAlD
Auranofin—PRDX5—skin of body—allergic rhinitis	0.0247	0.0844	CbGeAlD
Auranofin—PRDX5—trachea—allergic rhinitis	0.023	0.0784	CbGeAlD
Auranofin—IKBKB—respiratory system—allergic rhinitis	0.0184	0.0628	CbGeAlD
Auranofin—PRDX5—lung—allergic rhinitis	0.0165	0.0563	CbGeAlD
Auranofin—IKBKB—bronchus—allergic rhinitis	0.0152	0.0517	CbGeAlD
Auranofin—IKBKB—Endogenous TLR signaling—TLR1—allergic rhinitis	0.0151	0.0645	CbGpPWpGaD
Auranofin—IKBKB—skin of body—allergic rhinitis	0.0146	0.0499	CbGeAlD
Auranofin—PRDX5—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.0127	0.0539	CbGpPWpGaD
Auranofin—Hepatic enzyme increased—Desloratadine—allergic rhinitis	0.0119	0.0251	CcSEcCtD
Auranofin—IKBKB—lung—allergic rhinitis	0.00978	0.0334	CbGeAlD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.0088	0.0375	CbGpPWpGaD
Auranofin—IKBKB—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.00839	0.0357	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.00801	0.0341	CbGpPWpGaD
Auranofin—Glossitis—Flunisolide—allergic rhinitis	0.00725	0.0154	CcSEcCtD
Auranofin—IKBKB—IL17 signaling pathway—IL17A—allergic rhinitis	0.00708	0.0302	CbGpPWpGaD
Auranofin—Melaena—Cetirizine—allergic rhinitis	0.00664	0.0141	CcSEcCtD
Auranofin—Neuropathy peripheral—Cyproheptadine—allergic rhinitis	0.00632	0.0134	CcSEcCtD
Auranofin—Jaundice—Cyproheptadine—allergic rhinitis	0.00629	0.0133	CcSEcCtD
Auranofin—Agranulocytosis—Cyproheptadine—allergic rhinitis	0.00602	0.0128	CcSEcCtD
Auranofin—Conjunctivitis—Olopatadine—allergic rhinitis	0.00521	0.011	CcSEcCtD
Auranofin—Neuropathy peripheral—Diphenhydramine—allergic rhinitis	0.00514	0.0109	CcSEcCtD
Auranofin—Neuropathy peripheral—Dimenhydrinate—allergic rhinitis	0.00514	0.0109	CcSEcCtD
Auranofin—Agranulocytosis—Diphenhydramine—allergic rhinitis	0.0049	0.0104	CcSEcCtD
Auranofin—Agranulocytosis—Dimenhydrinate—allergic rhinitis	0.0049	0.0104	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.00476	0.0203	CbGpPWpGaD
Auranofin—IKBKB—Osteopontin Signaling—NFKB1—allergic rhinitis	0.00472	0.0201	CbGpPWpGaD
Auranofin—IKBKB—NF-kB is activated and signals survival—NFKB1—allergic rhinitis	0.00472	0.0201	CbGpPWpGaD
Auranofin—Visual impairment—Olopatadine—allergic rhinitis	0.00464	0.00983	CcSEcCtD
Auranofin—Leukopenia—Cyproheptadine—allergic rhinitis	0.00451	0.00956	CcSEcCtD
Auranofin—Eye disorder—Olopatadine—allergic rhinitis	0.0045	0.00953	CcSEcCtD
Auranofin—Angioedema—Desloratadine—allergic rhinitis	0.00448	0.00949	CcSEcCtD
Auranofin—IKBKB—Atypical NF-kappaB pathway—NFKB1—allergic rhinitis	0.00445	0.019	CbGpPWpGaD
Auranofin—Dysgeusia—Olopatadine—allergic rhinitis	0.0041	0.00869	CcSEcCtD
Auranofin—IKBKB—Downstream TCR signaling—HLA-DQB1—allergic rhinitis	0.00408	0.0174	CbGpPWpGaD
Auranofin—Thrombocytopenia—Cyproheptadine—allergic rhinitis	0.00403	0.00853	CcSEcCtD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.004	0.017	CbGpPWpGaD
Auranofin—IKBKB—p75NTR signals via NF-kB—NFKB1—allergic rhinitis	0.004	0.017	CbGpPWpGaD
Auranofin—Anorexia—Cyproheptadine—allergic rhinitis	0.00392	0.00831	CcSEcCtD
Auranofin—Anorexia—Desloratadine—allergic rhinitis	0.00381	0.00808	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.00375	0.016	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00371	0.0158	CbGpPWpGaD
Auranofin—Jaundice—Cetirizine—allergic rhinitis	0.00371	0.00785	CcSEcCtD
Auranofin—Stomatitis—Cetirizine—allergic rhinitis	0.00371	0.00785	CcSEcCtD
Auranofin—Conjunctivitis—Cetirizine—allergic rhinitis	0.0037	0.00783	CcSEcCtD
Auranofin—Stomatitis—Flunisolide—allergic rhinitis	0.00364	0.00772	CcSEcCtD
Auranofin—Conjunctivitis—Flunisolide—allergic rhinitis	0.00363	0.0077	CcSEcCtD
Auranofin—Haematuria—Cetirizine—allergic rhinitis	0.00363	0.00768	CcSEcCtD
Auranofin—Dyspepsia—Cyproheptadine—allergic rhinitis	0.00362	0.00767	CcSEcCtD
Auranofin—Decreased appetite—Cyproheptadine—allergic rhinitis	0.00358	0.00758	CcSEcCtD
Auranofin—Eosinophilia—Montelukast—allergic rhinitis	0.00354	0.0075	CcSEcCtD
Auranofin—Dyspepsia—Desloratadine—allergic rhinitis	0.00352	0.00746	CcSEcCtD
Auranofin—Constipation—Cyproheptadine—allergic rhinitis	0.00352	0.00745	CcSEcCtD
Auranofin—Decreased appetite—Desloratadine—allergic rhinitis	0.00348	0.00736	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—NFKB1—allergic rhinitis	0.00333	0.0142	CbGpPWpGaD
Auranofin—Visual impairment—Cetirizine—allergic rhinitis	0.00329	0.00697	CcSEcCtD
Auranofin—Thrombocytopenia—Diphenhydramine—allergic rhinitis	0.00328	0.00694	CcSEcCtD
Auranofin—Thrombocytopenia—Dimenhydrinate—allergic rhinitis	0.00328	0.00694	CcSEcCtD
Auranofin—Gastrointestinal pain—Desloratadine—allergic rhinitis	0.00327	0.00693	CcSEcCtD
Auranofin—Urticaria—Cyproheptadine—allergic rhinitis	0.00327	0.00692	CcSEcCtD
Auranofin—IKBKB—RIP-mediated NFkB activation via ZBP1—NFKB1—allergic rhinitis	0.00322	0.0137	CbGpPWpGaD
Auranofin—Alopecia—Loratadine—allergic rhinitis	0.00321	0.00679	CcSEcCtD
Auranofin—Eye disorder—Cetirizine—allergic rhinitis	0.00319	0.00676	CcSEcCtD
Auranofin—Anorexia—Dimenhydrinate—allergic rhinitis	0.00319	0.00676	CcSEcCtD
Auranofin—Anorexia—Diphenhydramine—allergic rhinitis	0.00319	0.00676	CcSEcCtD
Auranofin—Urticaria—Desloratadine—allergic rhinitis	0.00318	0.00673	CcSEcCtD
Auranofin—Abdominal pain—Desloratadine—allergic rhinitis	0.00316	0.0067	CcSEcCtD
Auranofin—Neuropathy peripheral—Montelukast—allergic rhinitis	0.00313	0.00662	CcSEcCtD
Auranofin—Jaundice—Montelukast—allergic rhinitis	0.00311	0.00658	CcSEcCtD
Auranofin—Conjunctivitis—Montelukast—allergic rhinitis	0.0031	0.00657	CcSEcCtD
Auranofin—Dysgeusia—Loratadine—allergic rhinitis	0.00309	0.00655	CcSEcCtD
Auranofin—IKBKB—TCR signaling—HLA-DQB1—allergic rhinitis	0.00305	0.013	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL17A—allergic rhinitis	0.00302	0.0129	CbGpPWpGaD
Auranofin—Alopecia—Cetirizine—allergic rhinitis	0.00302	0.00639	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—IL4—allergic rhinitis	0.003	0.0128	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—NFKB1—allergic rhinitis	0.00299	0.0127	CbGpPWpGaD
Auranofin—IKBKB—FCERI mediated NF-kB activation—NFKB1—allergic rhinitis	0.00299	0.0127	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—NFKB1—allergic rhinitis	0.00299	0.0127	CbGpPWpGaD
Auranofin—IKBKB—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.00299	0.0127	CbGpPWpGaD
Auranofin—Dyspepsia—Dimenhydrinate—allergic rhinitis	0.00295	0.00624	CcSEcCtD
Auranofin—Dyspepsia—Diphenhydramine—allergic rhinitis	0.00295	0.00624	CcSEcCtD
Auranofin—Flatulence—Cetirizine—allergic rhinitis	0.00293	0.0062	CcSEcCtD
Auranofin—Dysgeusia—Cetirizine—allergic rhinitis	0.00291	0.00616	CcSEcCtD
Auranofin—Decreased appetite—Dimenhydrinate—allergic rhinitis	0.00291	0.00616	CcSEcCtD
Auranofin—Decreased appetite—Diphenhydramine—allergic rhinitis	0.00291	0.00616	CcSEcCtD
Auranofin—IKBKB—TRAF6 mediated NF-kB activation—NFKB1—allergic rhinitis	0.00289	0.0123	CbGpPWpGaD
Auranofin—Angioedema—Loratadine—allergic rhinitis	0.00289	0.00611	CcSEcCtD
Auranofin—Constipation—Dimenhydrinate—allergic rhinitis	0.00286	0.00606	CcSEcCtD
Auranofin—Constipation—Diphenhydramine—allergic rhinitis	0.00286	0.00606	CcSEcCtD
Auranofin—Dysgeusia—Flunisolide—allergic rhinitis	0.00286	0.00606	CcSEcCtD
Auranofin—Pruritus—Desloratadine—allergic rhinitis	0.00283	0.00599	CcSEcCtD
Auranofin—Diarrhoea—Cyproheptadine—allergic rhinitis	0.00282	0.00596	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—ICAM1—allergic rhinitis	0.00281	0.012	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Olopatadine—allergic rhinitis	0.0028	0.00592	CcSEcCtD
Auranofin—Diarrhoea—Desloratadine—allergic rhinitis	0.00274	0.0058	CcSEcCtD
Auranofin—Angioedema—Cetirizine—allergic rhinitis	0.00272	0.00575	CcSEcCtD
Auranofin—IKBKB—ZBP1(DAI) mediated induction of type I IFNs—NFKB1—allergic rhinitis	0.00271	0.0116	CbGpPWpGaD
Auranofin—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NFKB1—allergic rhinitis	0.00271	0.0116	CbGpPWpGaD
Auranofin—Abdominal pain—Olopatadine—allergic rhinitis	0.0027	0.00573	CcSEcCtD
Auranofin—Urticaria—Dimenhydrinate—allergic rhinitis	0.00266	0.00563	CcSEcCtD
Auranofin—Urticaria—Diphenhydramine—allergic rhinitis	0.00266	0.00563	CcSEcCtD
Auranofin—Vomiting—Cyproheptadine—allergic rhinitis	0.00262	0.00554	CcSEcCtD
Auranofin—Rash—Cyproheptadine—allergic rhinitis	0.00259	0.0055	CcSEcCtD
Auranofin—Dermatitis—Cyproheptadine—allergic rhinitis	0.00259	0.00549	CcSEcCtD
Auranofin—Vomiting—Desloratadine—allergic rhinitis	0.00254	0.00539	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.00253	0.0108	CbGpPWpGaD
Auranofin—Rash—Desloratadine—allergic rhinitis	0.00252	0.00534	CcSEcCtD
Auranofin—Dermatitis—Desloratadine—allergic rhinitis	0.00252	0.00534	CcSEcCtD
Auranofin—Nausea—Cyproheptadine—allergic rhinitis	0.00244	0.00518	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL5—allergic rhinitis	0.00243	0.0103	CbGpPWpGaD
Auranofin—Pruritus—Olopatadine—allergic rhinitis	0.00242	0.00512	CcSEcCtD
Auranofin—Nausea—Desloratadine—allergic rhinitis	0.00238	0.00503	CcSEcCtD
Auranofin—Thrombocytopenia—Cetirizine—allergic rhinitis	0.00237	0.00503	CcSEcCtD
Auranofin—IKBKB—IL17 signaling pathway—NFKB1—allergic rhinitis	0.00236	0.01	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.00235	0.01	CbGpPWpGaD
Auranofin—Diarrhoea—Olopatadine—allergic rhinitis	0.00234	0.00496	CcSEcCtD
Auranofin—Anorexia—Cetirizine—allergic rhinitis	0.00231	0.0049	CcSEcCtD
Auranofin—Diarrhoea—Diphenhydramine—allergic rhinitis	0.00229	0.00485	CcSEcCtD
Auranofin—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.00229	0.00485	CcSEcCtD
Auranofin—Angioedema—Montelukast—allergic rhinitis	0.00228	0.00482	CcSEcCtD
Auranofin—Dyspepsia—Loratadine—allergic rhinitis	0.00227	0.00481	CcSEcCtD
Auranofin—Constipation—Loratadine—allergic rhinitis	0.0022	0.00467	CcSEcCtD
Auranofin—IKBKB—IL1-mediated signaling events—NFKB1—allergic rhinitis	0.00219	0.00932	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—CD4—allergic rhinitis	0.00219	0.00931	CbGpPWpGaD
Auranofin—Vomiting—Olopatadine—allergic rhinitis	0.00217	0.00461	CcSEcCtD
Auranofin—Rash—Olopatadine—allergic rhinitis	0.00216	0.00457	CcSEcCtD
Auranofin—Dermatitis—Olopatadine—allergic rhinitis	0.00215	0.00456	CcSEcCtD
Auranofin—Dyspepsia—Cetirizine—allergic rhinitis	0.00213	0.00452	CcSEcCtD
Auranofin—Vomiting—Dimenhydrinate—allergic rhinitis	0.00213	0.00451	CcSEcCtD
Auranofin—Vomiting—Diphenhydramine—allergic rhinitis	0.00213	0.00451	CcSEcCtD
Auranofin—Rash—Dimenhydrinate—allergic rhinitis	0.00211	0.00447	CcSEcCtD
Auranofin—Rash—Diphenhydramine—allergic rhinitis	0.00211	0.00447	CcSEcCtD
Auranofin—Decreased appetite—Cetirizine—allergic rhinitis	0.00211	0.00447	CcSEcCtD
Auranofin—Dermatitis—Dimenhydrinate—allergic rhinitis	0.00211	0.00447	CcSEcCtD
Auranofin—Dermatitis—Diphenhydramine—allergic rhinitis	0.00211	0.00447	CcSEcCtD
Auranofin—Gastrointestinal pain—Loratadine—allergic rhinitis	0.00211	0.00446	CcSEcCtD
Auranofin—Dyspepsia—Flunisolide—allergic rhinitis	0.0021	0.00445	CcSEcCtD
Auranofin—Constipation—Cetirizine—allergic rhinitis	0.00207	0.00439	CcSEcCtD
Auranofin—Decreased appetite—Flunisolide—allergic rhinitis	0.00207	0.00439	CcSEcCtD
Auranofin—Constipation—Flunisolide—allergic rhinitis	0.00204	0.00432	CcSEcCtD
Auranofin—Abdominal pain—Loratadine—allergic rhinitis	0.00204	0.00432	CcSEcCtD
Auranofin—Nausea—Olopatadine—allergic rhinitis	0.00203	0.0043	CcSEcCtD
Auranofin—Thrombocytopenia—Montelukast—allergic rhinitis	0.00199	0.00422	CcSEcCtD
Auranofin—Nausea—Diphenhydramine—allergic rhinitis	0.00199	0.00421	CcSEcCtD
Auranofin—Nausea—Dimenhydrinate—allergic rhinitis	0.00199	0.00421	CcSEcCtD
Auranofin—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.00198	0.0042	CcSEcCtD
Auranofin—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.00195	0.00413	CcSEcCtD
Auranofin—Urticaria—Cetirizine—allergic rhinitis	0.00193	0.00408	CcSEcCtD
Auranofin—IKBKB—Interleukin-1 signaling—NFKB1—allergic rhinitis	0.00192	0.00818	CbGpPWpGaD
Auranofin—Abdominal pain—Cetirizine—allergic rhinitis	0.00192	0.00406	CcSEcCtD
Auranofin—Urticaria—Flunisolide—allergic rhinitis	0.00189	0.00401	CcSEcCtD
Auranofin—Abdominal pain—Flunisolide—allergic rhinitis	0.00189	0.00399	CcSEcCtD
Auranofin—IKBKB—Downstream TCR signaling—NFKB1—allergic rhinitis	0.00188	0.00802	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.00185	0.00787	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—allergic rhinitis	0.00185	0.00787	CbGpPWpGaD
Auranofin—Dyspepsia—Montelukast—allergic rhinitis	0.00179	0.00379	CcSEcCtD
Auranofin—Diarrhoea—Loratadine—allergic rhinitis	0.00176	0.00374	CcSEcCtD
Auranofin—Weight decreased—Hydrocortisone—allergic rhinitis	0.00175	0.0037	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisolone—allergic rhinitis	0.00173	0.00366	CcSEcCtD
Auranofin—IKBKB—TNF receptor signaling pathway —NFKB1—allergic rhinitis	0.00172	0.00732	CbGpPWpGaD
Auranofin—Pruritus—Cetirizine—allergic rhinitis	0.00172	0.00363	CcSEcCtD
Auranofin—Conjunctivitis—Prednisolone—allergic rhinitis	0.00171	0.00363	CcSEcCtD
Auranofin—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.00169	0.00719	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Hydrocortisone—allergic rhinitis	0.00169	0.00358	CcSEcCtD
Auranofin—Pruritus—Flunisolide—allergic rhinitis	0.00169	0.00357	CcSEcCtD
Auranofin—Gastrointestinal pain—Montelukast—allergic rhinitis	0.00166	0.00352	CcSEcCtD
Auranofin—Diarrhoea—Cetirizine—allergic rhinitis	0.00166	0.00351	CcSEcCtD
Auranofin—Vomiting—Loratadine—allergic rhinitis	0.00164	0.00347	CcSEcCtD
Auranofin—IKBKB—TCR signaling—CD4—allergic rhinitis	0.00163	0.00696	CbGpPWpGaD
Auranofin—Diarrhoea—Flunisolide—allergic rhinitis	0.00163	0.00346	CcSEcCtD
Auranofin—Rash—Loratadine—allergic rhinitis	0.00163	0.00344	CcSEcCtD
Auranofin—Dermatitis—Loratadine—allergic rhinitis	0.00162	0.00344	CcSEcCtD
Auranofin—Urticaria—Montelukast—allergic rhinitis	0.00162	0.00342	CcSEcCtD
Auranofin—Abdominal pain—Montelukast—allergic rhinitis	0.00161	0.00341	CcSEcCtD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NFKB1—allergic rhinitis	0.00161	0.00685	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.00159	0.00337	CcSEcCtD
Auranofin—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.00159	0.00336	CcSEcCtD
Auranofin—Conjunctivitis—Triamcinolone—allergic rhinitis	0.00158	0.00334	CcSEcCtD
Auranofin—Vomiting—Cetirizine—allergic rhinitis	0.00154	0.00327	CcSEcCtD
Auranofin—Nausea—Loratadine—allergic rhinitis	0.00153	0.00324	CcSEcCtD
Auranofin—Rash—Cetirizine—allergic rhinitis	0.00153	0.00324	CcSEcCtD
Auranofin—Dermatitis—Cetirizine—allergic rhinitis	0.00153	0.00324	CcSEcCtD
Auranofin—Visual impairment—Prednisolone—allergic rhinitis	0.00153	0.00323	CcSEcCtD
Auranofin—Vomiting—Flunisolide—allergic rhinitis	0.00152	0.00321	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	0.00151	0.00644	CbGpPWpGaD
Auranofin—Rash—Flunisolide—allergic rhinitis	0.0015	0.00318	CcSEcCtD
Auranofin—Dermatitis—Flunisolide—allergic rhinitis	0.0015	0.00318	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—allergic rhinitis	0.00149	0.00636	CbGpPWpGaD
Auranofin—Weight decreased—Dexamethasone—allergic rhinitis	0.00149	0.00316	CcSEcCtD
Auranofin—Weight decreased—Betamethasone—allergic rhinitis	0.00149	0.00316	CcSEcCtD
Auranofin—IKBKB—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.00149	0.00634	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.00149	0.00634	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.00149	0.00634	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	0.00148	0.00632	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MS4A2—allergic rhinitis	0.00146	0.00621	CbGpPWpGaD
Auranofin—Eye disorder—Hydrocortisone—allergic rhinitis	0.00144	0.00306	CcSEcCtD
Auranofin—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.00144	0.00305	CcSEcCtD
Auranofin—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.00144	0.00305	CcSEcCtD
Auranofin—Nausea—Cetirizine—allergic rhinitis	0.00144	0.00305	CcSEcCtD
Auranofin—Pruritus—Montelukast—allergic rhinitis	0.00144	0.00305	CcSEcCtD
Auranofin—Conjunctivitis—Dexamethasone—allergic rhinitis	0.00143	0.00303	CcSEcCtD
Auranofin—Conjunctivitis—Betamethasone—allergic rhinitis	0.00143	0.00303	CcSEcCtD
Auranofin—Nausea—Flunisolide—allergic rhinitis	0.00142	0.003	CcSEcCtD
Auranofin—IKBKB—TCR signaling—NFKB1—allergic rhinitis	0.00141	0.006	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.0014	0.00598	CbGpPWpGaD
Auranofin—Visual impairment—Methylprednisolone—allergic rhinitis	0.0014	0.00296	CcSEcCtD
Auranofin—Diarrhoea—Montelukast—allergic rhinitis	0.00139	0.00295	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.00137	0.00584	CbGpPWpGaD
Auranofin—Eye disorder—Methylprednisolone—allergic rhinitis	0.00136	0.00287	CcSEcCtD
Auranofin—ALB—Folate Metabolism—IL4—allergic rhinitis	0.00135	0.00576	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.00132	0.00563	CbGpPWpGaD
Auranofin—IKBKB—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.0013	0.00555	CbGpPWpGaD
Auranofin—Vomiting—Montelukast—allergic rhinitis	0.00129	0.00274	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.00129	0.00548	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—NFKB1—allergic rhinitis	0.00129	0.00548	CbGpPWpGaD
Auranofin—Rash—Montelukast—allergic rhinitis	0.00128	0.00272	CcSEcCtD
Auranofin—Dermatitis—Montelukast—allergic rhinitis	0.00128	0.00271	CcSEcCtD
Auranofin—Visual impairment—Dexamethasone—allergic rhinitis	0.00127	0.0027	CcSEcCtD
Auranofin—Visual impairment—Betamethasone—allergic rhinitis	0.00127	0.0027	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	0.00127	0.00542	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—NFKB1—allergic rhinitis	0.00127	0.00542	CbGpPWpGaD
Auranofin—Angioedema—Prednisolone—allergic rhinitis	0.00126	0.00267	CcSEcCtD
Auranofin—Dysgeusia—Triamcinolone—allergic rhinitis	0.00124	0.00263	CcSEcCtD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.00124	0.00528	CbGpPWpGaD
Auranofin—Eye disorder—Dexamethasone—allergic rhinitis	0.00123	0.00261	CcSEcCtD
Auranofin—Eye disorder—Betamethasone—allergic rhinitis	0.00123	0.00261	CcSEcCtD
Auranofin—Angioedema—Hydrocortisone—allergic rhinitis	0.00123	0.0026	CcSEcCtD
Auranofin—Nausea—Montelukast—allergic rhinitis	0.00121	0.00256	CcSEcCtD
Auranofin—Alopecia—Dexamethasone—allergic rhinitis	0.00117	0.00247	CcSEcCtD
Auranofin—Alopecia—Betamethasone—allergic rhinitis	0.00117	0.00247	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CD4—allergic rhinitis	0.00117	0.00497	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—NFKB1—allergic rhinitis	0.00116	0.00495	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.00116	0.00495	CbGpPWpGaD
Auranofin—Angioedema—Triamcinolone—allergic rhinitis	0.00116	0.00245	CcSEcCtD
Auranofin—Angioedema—Methylprednisolone—allergic rhinitis	0.00116	0.00245	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.00113	0.00482	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKB1—allergic rhinitis	0.0011	0.0047	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—NFKB1—allergic rhinitis	0.00108	0.00461	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—ICAM1—allergic rhinitis	0.00107	0.00458	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—NFKB1—allergic rhinitis	0.00106	0.00452	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.00106	0.00452	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.00105	0.00448	CbGpPWpGaD
Auranofin—Angioedema—Dexamethasone—allergic rhinitis	0.00105	0.00223	CcSEcCtD
Auranofin—Angioedema—Betamethasone—allergic rhinitis	0.00105	0.00223	CcSEcCtD
Auranofin—Anorexia—Hydrocortisone—allergic rhinitis	0.00105	0.00222	CcSEcCtD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.00104	0.00444	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.00102	0.00436	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.001	0.00428	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000995	0.00424	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000987	0.0042	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	0.000987	0.0042	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.00097	0.00413	CbGpPWpGaD
Auranofin—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000967	0.00205	CcSEcCtD
Auranofin—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000955	0.00202	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000946	0.00403	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—NFKB1—allergic rhinitis	0.00093	0.00396	CbGpPWpGaD
Auranofin—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000919	0.00195	CcSEcCtD
Auranofin—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000919	0.00195	CcSEcCtD
Auranofin—Dyspepsia—Triamcinolone—allergic rhinitis	0.00091	0.00193	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000908	0.00387	CbGpPWpGaD
Auranofin—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000908	0.00192	CcSEcCtD
Auranofin—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000898	0.0019	CcSEcCtD
Auranofin—Anorexia—Betamethasone—allergic rhinitis	0.000894	0.00189	CcSEcCtD
Auranofin—Anorexia—Dexamethasone—allergic rhinitis	0.000894	0.00189	CcSEcCtD
Auranofin—Urticaria—Prednisolone—allergic rhinitis	0.000893	0.00189	CcSEcCtD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000884	0.00377	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000876	0.00373	CbGpPWpGaD
Auranofin—Urticaria—Hydrocortisone—allergic rhinitis	0.000872	0.00185	CcSEcCtD
Auranofin—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000868	0.00184	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000868	0.0037	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000853	0.00364	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MS4A2—allergic rhinitis	0.000849	0.00362	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000844	0.00179	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000837	0.00357	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000836	0.00356	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	0.000836	0.00356	CbGpPWpGaD
Auranofin—Dyspepsia—Betamethasone—allergic rhinitis	0.000826	0.00175	CcSEcCtD
Auranofin—Dyspepsia—Dexamethasone—allergic rhinitis	0.000826	0.00175	CcSEcCtD
Auranofin—Urticaria—Triamcinolone—allergic rhinitis	0.000822	0.00174	CcSEcCtD
Auranofin—Urticaria—Methylprednisolone—allergic rhinitis	0.00082	0.00174	CcSEcCtD
Auranofin—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000816	0.00173	CcSEcCtD
Auranofin—Decreased appetite—Dexamethasone—allergic rhinitis	0.000816	0.00173	CcSEcCtD
Auranofin—Decreased appetite—Betamethasone—allergic rhinitis	0.000816	0.00173	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000787	0.00335	CbGpPWpGaD
Auranofin—Pruritus—Hydrocortisone—allergic rhinitis	0.000777	0.00165	CcSEcCtD
Auranofin—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000767	0.00163	CcSEcCtD
Auranofin—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000767	0.00163	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—HLA-G—allergic rhinitis	0.000756	0.00322	CbGpPWpGaD
Auranofin—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000751	0.00159	CcSEcCtD
Auranofin—Urticaria—Dexamethasone—allergic rhinitis	0.000745	0.00158	CcSEcCtD
Auranofin—Urticaria—Betamethasone—allergic rhinitis	0.000745	0.00158	CcSEcCtD
Auranofin—Abdominal pain—Dexamethasone—allergic rhinitis	0.000742	0.00157	CcSEcCtD
Auranofin—Abdominal pain—Betamethasone—allergic rhinitis	0.000742	0.00157	CcSEcCtD
Auranofin—Pruritus—Triamcinolone—allergic rhinitis	0.000732	0.00155	CcSEcCtD
Auranofin—Pruritus—Methylprednisolone—allergic rhinitis	0.00073	0.00155	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000723	0.00308	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000709	0.00302	CbGpPWpGaD
Auranofin—Rash—Prednisolone—allergic rhinitis	0.000709	0.0015	CcSEcCtD
Auranofin—Dermatitis—Prednisolone—allergic rhinitis	0.000708	0.0015	CcSEcCtD
Auranofin—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000706	0.0015	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000701	0.00299	CbGpPWpGaD
Auranofin—Vomiting—Hydrocortisone—allergic rhinitis	0.000698	0.00148	CcSEcCtD
Auranofin—Rash—Hydrocortisone—allergic rhinitis	0.000692	0.00147	CcSEcCtD
Auranofin—Dermatitis—Hydrocortisone—allergic rhinitis	0.000692	0.00147	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000689	0.00294	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—NFKB1—allergic rhinitis	0.00068	0.0029	CbGpPWpGaD
Auranofin—Nausea—Prednisolone—allergic rhinitis	0.000668	0.00141	CcSEcCtD
Auranofin—Pruritus—Betamethasone—allergic rhinitis	0.000664	0.00141	CcSEcCtD
Auranofin—Pruritus—Dexamethasone—allergic rhinitis	0.000664	0.00141	CcSEcCtD
Auranofin—Vomiting—Triamcinolone—allergic rhinitis	0.000657	0.00139	CcSEcCtD
Auranofin—Vomiting—Methylprednisolone—allergic rhinitis	0.000656	0.00139	CcSEcCtD
Auranofin—Nausea—Hydrocortisone—allergic rhinitis	0.000652	0.00138	CcSEcCtD
Auranofin—Rash—Triamcinolone—allergic rhinitis	0.000652	0.00138	CcSEcCtD
Auranofin—Dermatitis—Triamcinolone—allergic rhinitis	0.000651	0.00138	CcSEcCtD
Auranofin—Rash—Methylprednisolone—allergic rhinitis	0.000651	0.00138	CcSEcCtD
Auranofin—Dermatitis—Methylprednisolone—allergic rhinitis	0.00065	0.00138	CcSEcCtD
Auranofin—Diarrhoea—Betamethasone—allergic rhinitis	0.000642	0.00136	CcSEcCtD
Auranofin—Diarrhoea—Dexamethasone—allergic rhinitis	0.000642	0.00136	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.00064	0.00273	CbGpPWpGaD
Auranofin—Nausea—Triamcinolone—allergic rhinitis	0.000614	0.0013	CcSEcCtD
Auranofin—Nausea—Methylprednisolone—allergic rhinitis	0.000613	0.0013	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000612	0.00261	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000609	0.0026	CbGpPWpGaD
Auranofin—Vomiting—Betamethasone—allergic rhinitis	0.000597	0.00126	CcSEcCtD
Auranofin—Vomiting—Dexamethasone—allergic rhinitis	0.000597	0.00126	CcSEcCtD
Auranofin—Rash—Dexamethasone—allergic rhinitis	0.000592	0.00125	CcSEcCtD
Auranofin—Rash—Betamethasone—allergic rhinitis	0.000592	0.00125	CcSEcCtD
Auranofin—Dermatitis—Dexamethasone—allergic rhinitis	0.000591	0.00125	CcSEcCtD
Auranofin—Dermatitis—Betamethasone—allergic rhinitis	0.000591	0.00125	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000584	0.00249	CbGpPWpGaD
Auranofin—Nausea—Betamethasone—allergic rhinitis	0.000557	0.00118	CcSEcCtD
Auranofin—Nausea—Dexamethasone—allergic rhinitis	0.000557	0.00118	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—NFKB1—allergic rhinitis	0.000541	0.0023	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.00054	0.0023	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000508	0.00216	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—allergic rhinitis	0.000486	0.00207	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000472	0.00201	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTGDR2—allergic rhinitis	0.000467	0.00199	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	0.000463	0.00197	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-G—allergic rhinitis	0.000459	0.00195	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000405	0.00173	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NFKB1—allergic rhinitis	0.000398	0.0017	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL5—allergic rhinitis	0.000373	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL5—allergic rhinitis	0.00037	0.00158	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000366	0.00156	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL11—allergic rhinitis	0.000354	0.00151	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ICAM1—allergic rhinitis	0.000344	0.00147	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DQB1—allergic rhinitis	0.000286	0.00122	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—allergic rhinitis	0.000264	0.00112	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TAC1—allergic rhinitis	0.000257	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—allergic rhinitis	0.000253	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL5—allergic rhinitis	0.000239	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFKB1—allergic rhinitis	0.000227	0.000968	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NFKB1—allergic rhinitis	0.000218	0.000929	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000215	0.000918	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—allergic rhinitis	0.000209	0.00089	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMAD3—allergic rhinitis	0.000168	0.000717	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—allergic rhinitis	0.000154	0.000654	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKB1—allergic rhinitis	0.000132	0.000564	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—allergic rhinitis	0.000111	0.000473	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKB1—allergic rhinitis	8.55e-05	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—allergic rhinitis	7.12e-05	0.000304	CbGpPWpGaD
